Glenmark Gets Russian Health Ministry'S Nod To Market Allergic Rhinitis Tablets

Glenmark Gets Russian Health Ministry'S Nod To Market Allergic Rhinitis Tablets

By, Admin 1 October 2019

Drug Firm Glenmark Pharmaceuticals On Monday Said It Has Received Approval From The Ministry Of Healthcare, Russia, To Market Montlezir Film-Coated Tablets Used For Treatment Of Allergic Rhinitis. Montlezir Is Expected To Be Available In The Russian Market In Third Quarter Of Financial Year 2019-20, Glenmark Said In A Bse Filing."Russia Is One Of The Key Markets For Us And We Are Consistently Looking To Expand Our Product Portfolio," Glenmark Pharmaceuticals Senior Vice President And Head - Asia, Russia And Cis Region Csaba Kantor Said.Glenmark Has Built Strong Capabilities In The Respiratory Space And Is Among The Leading Players In This Therapy Area Across Several Markets Globally, He Added.According To Iqvia, In The Respiratory Space, Glenmark Continues To Secure A Strong Position And Ranked Fourth Amongst The Companies Present In The Expectorants Market In Russia As Of Mat July 2019, The Company Said.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!